These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 26831744

  • 1. Kidney Disease Progression in Autosomal Recessive Polycystic Kidney Disease.
    Dell KM, Matheson M, Hartung EA, Warady BA, Furth SL, Chronic Kidney Disease in Children (CKiD) Study.
    J Pediatr; 2016 Apr; 171():196-201.e1. PubMed ID: 26831744
    [Abstract] [Full Text] [Related]

  • 2. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 3. Cardiac Abnormalities in Children with Autosomal Recessive Polycystic Kidney Disease.
    Chinali M, Lucchetti L, Ricotta A, Esposito C, D'Anna C, Rinelli G, Emma F, Massella L.
    Cardiorenal Med; 2019 Jun 28; 9(3):180-189. PubMed ID: 30844805
    [Abstract] [Full Text] [Related]

  • 4. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
    Am J Kidney Dis; 2009 Apr 28; 53(4):606-16. PubMed ID: 19216016
    [Abstract] [Full Text] [Related]

  • 5. Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.
    Fathallah-Shaykh SA, Flynn JT, Pierce CB, Abraham AG, Blydt-Hansen TD, Massengill SF, Moxey-Mims MM, Warady BA, Furth SL, Wong CS.
    Clin J Am Soc Nephrol; 2015 Apr 07; 10(4):571-7. PubMed ID: 25635034
    [Abstract] [Full Text] [Related]

  • 6. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C.
    Transplant Proc; 2011 Apr 07; 43(6):2187-90. PubMed ID: 21839229
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.
    Lilova M, Kaplan BS, Meyers KE.
    Pediatr Nephrol; 2003 Jan 07; 18(1):57-61. PubMed ID: 12488992
    [Abstract] [Full Text] [Related]

  • 8. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Jan 07; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 9. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 07; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 10. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
    Seeman T, Fořtová M, Sopko B, Průša R, Pohl M, John U.
    Ann Clin Biochem; 2019 Jan 07; 56(1):90-94. PubMed ID: 29874928
    [Abstract] [Full Text] [Related]

  • 11. Strict blood-pressure control and progression of renal failure in children.
    ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
    N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
    [Abstract] [Full Text] [Related]

  • 12. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 22; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 13. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G.
    Kidney Int; 1998 May 22; 53(5):1209-16. PubMed ID: 9573535
    [Abstract] [Full Text] [Related]

  • 14. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S.
    Hypertens Res; 2008 Mar 22; 31(3):433-41. PubMed ID: 18497462
    [Abstract] [Full Text] [Related]

  • 15. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.
    Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, Kaskel F, Furth SL, Schwartz GJ, CKiD Investigators.
    Clin J Am Soc Nephrol; 2009 Apr 22; 4(4):812-9. PubMed ID: 19297612
    [Abstract] [Full Text] [Related]

  • 16. Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study.
    Hartung EA, Matheson M, Lande MB, Dell KM, Guay-Woodford LM, Gerson AC, Warady BA, Hooper SR, Furth SL.
    Pediatr Nephrol; 2014 Oct 22; 29(10):1957-65. PubMed ID: 24828609
    [Abstract] [Full Text] [Related]

  • 17. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T, Dusek J, Vondrák K, Flögelová H, Geier P, Janda J.
    Am J Hypertens; 2004 May 22; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [Abstract] [Full Text] [Related]

  • 18. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
    Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME.
    J Am Soc Nephrol; 1995 Jun 22; 5(12):2037-47. PubMed ID: 7579052
    [Abstract] [Full Text] [Related]

  • 19. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.
    Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE.
    Kidney Int; 2010 Aug 22; 78(3):303-9. PubMed ID: 20445497
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease.
    Fleischer LT, Ballester L, Dutt M, Howarth K, Poznick L, Darge K, Furth SL, Hartung EA.
    J Nephrol; 2023 Jan 22; 36(1):133-145. PubMed ID: 35980535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.